NCT01180530View on ClinicalTrials.gov

Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

358

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
DiabetesDiabetes Mellitus, Type 1Delivery Systems
Interventions
DEVICE

NovoPen Echo®

Prescribed insulin treatment delivered by NovoPen Echo®

Trial Locations (5)

44425

Novo Nordisk Investigational Site, Kfar Saba

L4W 4XI

Novo Nordisk Investigational Site, Mississauga

FI-02600

Novo Nordisk Investigational Site, Espoo

202 15

Novo Nordisk Investigational Site, Malmo

SE-202 15

Novo Nordisk Investigational Site, Malmo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY